Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer

Annals of Oncology : Official Journal of the European Society for Medical Oncology
S ChanL W Lee

Abstract

To ascertain the efficacy and tolerability of non-pegylated liposomal doxorubicin (Myocet) and epirubicin combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer. One hundred and sixty anthracycline-naïve metastatic breast cancer patients were randomised to receive Myocet (M; 75 mg/m(2)) or epirubicin (E; 75 mg/m(2)) in combination with cyclophosphamide (C; 600 mg/m(2)), every 3 weeks for up to eight cycles. Response (overall response = complete + partial response rates), time to disease progression, overall survival and cardiac function (left ventricular ejection fraction). Overall response rates were 46% and 39% for MC and EC treatment, respectively (P=0.42). MC was superior to EC with respect to median time to treatment failure (5.7 versus 4.4 months; P=0.01) and median time to disease progression (7.7 versus 5.6 months; P=0.02). Median survival times were 18.3 and 16.0 months for MC and EC, respectively (P=0.504). Unsurprisingly, given an equimolar comparison, neutropenia and stomatitis/mucositis were significantly more common in patients who received MC. However, there was less injection site toxicity with MC. Both treatments showed a low incidence of cardiotoxicity. Myocet appe...Continue Reading

References

Nov 1, 1979·Annals of Internal Medicine·D D Von HoffF M Muggia
Jan 1, 1990·Acta Oncologica·H T MouridsenT Skovsgård
Apr 13, 2000·The New England Journal of Medicine·G M FelkerE K Kasper
Jun 22, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B V JensenS L Nielsen
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George W SledgeWilliam C Wood
Feb 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R ParidaensN Azli

❮ Previous
Next ❯

Citations

Jan 5, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Orit FreedmanMark Clemons
Jan 3, 2008·Breast Cancer Research and Treatment·Justin StebbingPeter Barrett-Lee
Jan 21, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P J Barrett-LeeM W Verrill
Oct 20, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AaproU Wedding
Feb 4, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H A AzimM J Piccart
Oct 15, 2005·Current Opinion in Oncology·Hans Wildiers, Etienne G C Brain
Feb 13, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R AngioliP Benedetti Panici
Dec 6, 2012·Experimental Hematology & Oncology·Shamudheen M RafiyathDelong Liu
Mar 13, 2012·The AAPS Journal·Neil Desai
Oct 3, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M LuqueY Fernández
Sep 1, 2007·Women's Health·M ShehataS Chan
Mar 12, 2009·Expert Review of Anticancer Therapy·Giuseppe Visani, Alessandro Isidori
Dec 3, 2008·Expert Review of Anticancer Therapy·Flora Stavridi, Carlo Palmieri
Mar 28, 2008·Expert Review of Anticancer Therapy·Alessandro M MinisiniFabio Puglisi
Oct 19, 2006·Expert Opinion on Drug Safety·Robin L JonesMichael S Ewer
May 8, 2007·Expert Opinion on Drug Safety·Raymond Ng, Michael D Green
May 6, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joseph W Nichols, You Han Bae
Dec 30, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Andreas WickiJörg Huwyler
Jan 21, 2012·The Breast : Official Journal of the European Society of Mastology·Mustafa KhasrawChau Dang
Oct 11, 2011·Drug Discovery Today·Marije SlingerlandHans Gelderblom
Aug 7, 2009·The Breast : Official Journal of the European Society of Mastology·R C F LeonardS Oliveros
Mar 10, 2009·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Davinder S JassalPawan K Singal
Aug 30, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nicholas Wilcken, Rachel Dear
Sep 8, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Norihiro YamaguchiRonald H Blum
May 2, 2013·Journal of Drug Delivery·Juan LaoAntonio Antón Torres
Oct 8, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Darren Lars StirlandYou Han Bae
Sep 17, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E CurtitL Cals
Jul 2, 2016·Pharmacological Reviews·Phatsapong YingchoncharoenDes R Richardson
Apr 28, 2016·Expert Opinion on Drug Safety·Guido GiordanoAntonio Febbraro
Jul 28, 2016·The British Journal of Radiology·Maria C De SantisVincenzo Valentini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

© 2021 Meta ULC. All rights reserved